Writing in the journal Microbiome, researchers from the Massachusetts Institute of Technology reported that fucoidan, a marine polysaccharide from brown seaweed, offers broad-spectrum growth protection against multiple types of antibiotics both in vitro and ex vivo. They noted that this may be the first time a specific dietary supplement, sulfated polysaccharides, has been found to counteract the antibiotic inhibition of bacterial isolates and communities.